Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients

NCT02790073 is registered in ClinicalTrials.gov with Sanifit Therapeutics S. A. as lead sponsor.

NCT NCT02790073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02790073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Lead sponsor
Sanifit Therapeutics S. A.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2016
Completion date
November 15, 2017
Enrollment
14 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

calcific uremic arteriolopathy, calciphylaxis